Air India has been awarded the Good Distribution Practices (GDP) certification for its cargo business, recognizing its commitment to delivering high-quality logistics solutions for pharmaceutical products. The certification validates the airline’s compliance with international guidelines for the safe and secure distribution of pharmaceuticals. In the financial year 2024-25, Air India transported over 4,000 tonnes of pharmaceuticals globally, highlighting its significant role in the industry.
The GDP certification is a significant achievement for Air India, as India is one of the world’s key exporters of pharmaceutical products. The certification assures partners globally that Air India is fully equipped to safeguard the integrity of every shipment. The airline’s GDP-certified stations include major cargo hubs in India, such as Delhi, Mumbai, and Hyderabad, as well as international gateways like New York, London, and Amsterdam.
To strengthen its pharmaceutical handling capabilities, Air India has made significant investments in enhancing its infrastructure and processes. These include partnering with GDP-certified cargo terminal operators, providing specialized training for cargo staff, and procuring essential equipment such as thermal blankets and cool dollies. The airline has also implemented robust quality systems, including end-to-end documentation and monitoring processes, to guarantee traceability and compliance with global standards.
The GDP certification was awarded after a rigorous audit that included checks for quality manuals, temperature-controlled warehouse and equipment, and risk management processes. Air India’s Head of Cargo, Ramesh Mamidala, stated that the certification is a “shot in the arm” for the airline’s expertise and capabilities in specialized logistics, and assures partners that the airline is fully equipped to handle pharmaceutical shipments.
The certification is expected to enhance Air India’s ability to transport vaccines, biologics, and other high-value medical goods, both within India and globally. With its strengthened pharmaceutical handling capabilities and GDP certification, Air India is well-positioned to meet the growing demand for specialized logistics solutions in the pharmaceutical industry. The airline’s commitment to quality and compliance with international standards is expected to increase customer confidence and drive growth in its cargo business.